DIRECT SAMPLE ANALYSIS WITH AN ATMOSPHERIC PRESSURE GLOW DISCHARGE
利用大气压辉光放电进行直接样品分析
基本信息
- 批准号:7611686
- 负责人:
- 金额:$ 10.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-02-09 至 2010-02-08
- 项目状态:已结题
- 来源:
- 关键词:AblationAcuteAddressAirAnodesAreaAtmospheric PressureBiochemicalBiologicalBiological AssayBiological SciencesBiomedical ResearchCathodesCellsCellular StructuresCharacteristicsChargeChemicalsClinicalCouplingCytochrome P450DetectionDevelopmentDiffuseElectrodesElectronsElectrospray IonizationEnvironmentHandIACUCImageIn VitroIndianaIonsLaboratoriesLasersLateralLettersLibrariesMarketingMass Spectrum AnalysisMeasurementMeasuresMedicalMethodsModificationNatureNephrologyNeurologyPerformancePharmacologic SubstancePhasePlasmaPreparationProceduresReagentResearch Ethics CommitteesResolutionSamplingSchemeScreening procedureSmall Business Technology Transfer ResearchSourceSpatial DistributionSpottingsStructureSurfaceSystemTechniquesTechnologyTemperatureTimeTissuesUniversitiesbasecombinatorialcommercializationdensitydesignhigh throughput screeningin vivoinnovationinstrumentationinterestion mobilityion sourceionizationionization techniquemass spectrometermedical schoolsmolecular imagingnew technologyoncologyplanetary Atmospherepre-clinicalprototypepublic health relevancetool
项目摘要
DESCRIPTION (provided by applicant): The overall objective of this Phase I STTR project is the commercialization of a new ionization source for ambient mass spectrometry based on the flowing afterglow of an atmospheric pressure glow discharge (APGD). This technology promises to have significant impact in pharmaceutical, clinical and biomedical research and its potential for enabling in vivo mass spectrometry detection in combination with existing technology is real. There is an acute need for the development of new technologies which enable rapid measurements with minimal sample pretreatment. Minimizing up-front sample preparation increases sample through-put by reducing the time required to go from raw material to a result. The recent development of ambient mass spectrometry methods has already resulted in the successful commercialization of just a few of these disruptive technologies. This project involves the fundamental characterization, optimization and development of a new direct sampling technology for mass spectrometry based on the flowing afterglow of an atmospheric pressure glow discharge developed at Indiana University by Prof. Gary Heiftje. Atmospheric pressure glow discharges have been extensively studied but not until very recently has it been attempted to use an atmospheric pressure glow discharge for direct sampling of surfaces in the open ambient air. We envision commercial ion sources that can be easily converted among several atmospheric pressure ionization techniques and can be retro-fitted to several different types of mass spectrometers or ion mobility spectrometers. The specific aims of this Phase I STTR proposal are: Aim 1: Investigate the APGD and flowing afterglow chemical environment using spectroscopic techniques. Aim 2: Identify electrode structures and materials for the anode and cathode in an attempt to optimize the atmospheric glow discharge characteristics using the information gained through completion of Aim 1. An "optimized" cell will be one which maximizes reagent ion density and controls their spatial distribution. Aim 3: Operate the APGD cell in combination with mass spectrometry and identify operating conditions for the cell geometries investigated in Aim 2. Aim 4: Assess the feasibility for coupling APGD to a commercial laser ablation mass spectrometry system. Phase II of this project will include the development of a commercial prototype of the APGD ion source based on the criteria defined in Phase I, further optimization of its performance and robustness, comparisons to other ambient ionization methods and applications development in the areas of pharmaceutical and biomedical research. Specifically, Phase II will focus in part on the development of the APGD cell in combination with commercially available laser ablation mass spectrometry systems, which will enable direct, 3D molecular imaging of biological tissues. Other application areas that will be explored with the same instrumentation include high throughput screening of combinatorial libraries and in vitro cytochrome P450 assays. PUBLIC HEALTH RELEVANCE: Prosolia's new and versatile ambient ionization source for mass spectrometry promises to enable high throughput chemical screening that will significantly impact pharmaceutical, clinical and biomedical research.
描述(由申请人提供):第一阶段 STTR 项目的总体目标是基于大气压辉光放电 (APGD) 的流动余辉,实现用于环境质谱分析的新型电离源的商业化。该技术有望对制药、临床和生物医学研究产生重大影响,并且其与现有技术相结合实现体内质谱检测的潜力是真实的。迫切需要开发新技术,以最少的样品预处理实现快速测量。最大限度地减少前期样品制备,减少从原材料到结果所需的时间,从而提高样品通量。环境质谱方法的最新发展已经导致其中一些颠覆性技术成功商业化。该项目涉及一种新的质谱直接采样技术的基本表征、优化和开发,该技术基于印第安纳大学 Gary Heiftje 教授开发的大气压辉光放电的流动余辉。大气压辉光放电已被广泛研究,但直到最近才尝试使用大气压辉光放电对开放环境空气中的表面进行直接采样。我们设想商业离子源可以在几种大气压电离技术之间轻松转换,并且可以改装到几种不同类型的质谱仪或离子迁移谱仪。第一阶段 STTR 提案的具体目标是: 目标 1:使用光谱技术研究 APGD 和流动余辉化学环境。目标 2:确定阳极和阴极的电极结构和材料,以尝试使用通过完成目标 1 获得的信息来优化大气辉光放电特性。“优化”电池将是一种最大化试剂离子密度并控制其空间的电池分配。目标 3:结合质谱分析操作 APGD 池,并确定目标 2 中研究的细胞几何形状的操作条件。目标 4:评估将 APGD 耦合到商用激光烧蚀质谱系统的可行性。该项目的第二阶段将包括根据第一阶段定义的标准开发 APGD 离子源的商业原型,进一步优化其性能和稳健性,与其他环境电离方法进行比较以及制药和制药领域的应用开发。生物医学研究。具体来说,第二阶段将部分侧重于与市售激光烧蚀质谱系统相结合的 APGD 细胞的开发,这将实现生物组织的直接 3D 分子成像。将使用相同仪器探索的其他应用领域包括组合文库的高通量筛选和体外细胞色素 P450 测定。 公共健康相关性:Prosolia 用于质谱分析的新型多功能环境电离源有望实现高通量化学筛选,这将显着影响制药、临床和生物医学研究。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ultrasensitive ambient mass spectrometric analysis with a pin-to-capillary flowing atmospheric-pressure afterglow source.
- DOI:10.1021/ac201053q
- 发表时间:2011-07-15
- 期刊:
- 影响因子:7.4
- 作者:Shelley, Jacob T.;Wiley, Joshua S.;Hieftje, Gary M.
- 通讯作者:Hieftje, Gary M.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Justin Michael Wiseman其他文献
Justin Michael Wiseman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Justin Michael Wiseman', 18)}}的其他基金
All-in-one Device for Forensic Toxicology Drug Screening
用于法医毒理学药物筛选的一体化设备
- 批准号:
10482653 - 财政年份:2022
- 资助金额:
$ 10.2万 - 项目类别:
All-in-one Device for Forensic Toxicology Drug Screening
用于法医毒理学药物筛选的一体化设备
- 批准号:
10743053 - 财政年份:2022
- 资助金额:
$ 10.2万 - 项目类别:
DEVELOPMENT OF AN INTELLIGENT SAMPLE INTRODUCTION SYSTEM FOR MASS SPECTROMETRY
质谱智能进样系统的开发
- 批准号:
8590085 - 财政年份:2013
- 资助金额:
$ 10.2万 - 项目类别:
Development of a Novel Atmospheric Pressure Glow Discharge for Ambient Mass Spect
用于环境质谱的新型大气压辉光放电的开发
- 批准号:
8301546 - 财政年份:2009
- 资助金额:
$ 10.2万 - 项目类别:
Development of a Novel Atmospheric Pressure Glow Discharge for Ambient Mass Spect
用于环境质谱的新型大气压辉光放电的开发
- 批准号:
8198467 - 财政年份:2009
- 资助金额:
$ 10.2万 - 项目类别:
相似国自然基金
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
活性脂质Arlm-1介导的自噬流阻滞在儿童T细胞急性淋巴细胞白血病化疗耐药逆转中的作用机制研究
- 批准号:82300182
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Functional, structural, and computational consequences of NMDA receptor ablation at medial prefrontal cortex synapses
内侧前额皮质突触 NMDA 受体消融的功能、结构和计算后果
- 批准号:
10677047 - 财政年份:2023
- 资助金额:
$ 10.2万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 10.2万 - 项目类别:
LRP1 as a novel regulator of CXCR4 in adult neural stem cells and post-stroke response
LRP1 作为成体神经干细胞和中风后反应中 CXCR4 的新型调节剂
- 批准号:
10701231 - 财政年份:2023
- 资助金额:
$ 10.2万 - 项目类别:
Mechanisms of Cardiac Injury Resolution by CX3CR1+ Macrophages
CX3CR1巨噬细胞解决心脏损伤的机制
- 批准号:
10719459 - 财政年份:2023
- 资助金额:
$ 10.2万 - 项目类别:
Investigating cerebrovascular dysfunction and cerebral atrophy in severe traumatic brain injury
严重颅脑损伤中脑血管功能障碍和脑萎缩的调查
- 批准号:
10742569 - 财政年份:2023
- 资助金额:
$ 10.2万 - 项目类别: